The extent of bisexual behaviour in HIV-infected men and implications for transmission to their female sex partners.

Heterosexual transmission of HIV is a growing problem for women, but many women do not know how their partners acquired HIV. We described a group of HIV-infected men and women, and focused on: (1) sexual identity and bisexual behaviour in men, and (2) the proportion of women who acknowledged having a bisexual male partner. This study examined HIV-infected persons who participated in a cross-sectional interview project from January 1995 through July 2000; 5,156 men who have sex with men (MSM), and 3,139 women. The proportion of MSM who reported having sex with women (MSM/MSW) varied by race: 34% of black MSM, 26% of Hispanic MSM, and 13% of white MSM. While 14% of white women acknowledged having a bisexual partner, only 6% of black and 6% of Hispanic women reported having a bisexual partner. Most behaviourally bisexual men identified as either bisexual (59%) or homosexual (26%). Among MSM/MSW, 30% had more female partners than male partners, while only 10% had more male partners than female partners. These data suggest that bisexual activity is relatively common among black and Hispanic HIV-infected MSM, few identify as heterosexual, and their female partners may not know of their bisexual activity.

Motivational factors in the choice of postdoctoral general dentistry programs.

This study explored the importance of various personal and professional factors that may influence choices concerning postdoctoral training in general dentistry. We sent an eighty-one-question survey to all individuals (N = 1,995) who were registered to participate in the Postdoctoral Dental Matching Program (MATCH) and analyzed 599 returned surveys from those applying to GPR and/or AEGD programs. Approximately twenty questions addressed each of four time periods in the application process. Over half of respondents felt that learning more medicine, increasing their speed with dental procedures, gaining confidence in clinical skills, and treating compromised patients were very important. Over one-third of respondents felt that program location, salary and benefits, program philosophy and faculty, and nondental training experiences were very important. Females felt that thirty-five items were more important than did their male counterparts, whereas males indicated that two items were more important. While there were some differences between applicants to AEGD versus GPR programs, there were far more areas where the applicants to each of these programs shared common concerns. The data suggest that the majority of individuals who consider postgraduate general dentistry programs perceive a lack of experience at the predoctoral level relating to clinical dentistry in general and specifically to their understanding of medical principles and managing compromised patients.

Pilot study of controlled-release pilocarpine in normal subjects.

OBJECTIVES: Current systemic treatments with sialogogues for patients with xerostomia are limited because of minimal efficacy, short duration of activity, or problems with side effects. The purpose of this pilot study was an initial assessment of safety, efficacy, duration of action, multiple dose tolerance, and side effects of a controlled-release formulation of pilocarpine hydrochloride. STUDY DESIGN: Eight healthy hospitalized subjects were given 15 mg of a controlled-release pilocarpine formulation every 12 hours for three doses. Saliva and blood samples were collected at assigned intervals. Repeated measures analysis and paired t tests were used for statistical analyses. RESULTS: A significant (p < 0.05) increase in both parotid and whole saliva output followed all three doses beginning within 1 hour of dosing and lasting over 10 hours. Mean plasma pilocarpine concentration reached a maximum of 8.2 ng/ml at approximately 1 hour after the first dose, 11.5 ng/ml after the third dose, and declined to near baseline (0.06 ng/ml) 24 hours after the final dose. None of the participants showed evidence of adverse effects including complaints of sweating or gastrointestinal discomfort. CONCLUSIONS: A controlled-release formulation of pilocarpine may overcome the therapeutic weaknesses of current pilocarpine preparations by prolonging salivary secretion and reducing undesirable side effects.